To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Indian secondaries: getting across the line
A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.
